You are here

Mpox: WHO approves a vaccine for adolescents, Zimbabwe reports first cases

Primary tabs

Mon, 2024-10-14 10:59 — mike kraft

WHO approves Bavarian Nordic's mpox vaccine for adolescents The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the disease that has triggered global concern. Reuters Reuters

ALSO SEE: Zimbabwe reports first two mpox cases of unspecified variant

Country / Region Tags:

General Topic Tags:

Disease Prevention

Social behavior

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Группа с ограниченным доступом -

Log in or register to post comments

Page loaded in 0.492 seconds.